CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3) - Wu, Y-L; Ahn, M-J; Garassino, MC (J Clin Oncol, 2018)
et al.